Vistisen, Dorte http://orcid.org/0000-0001-5045-5351
Kivimäki, Mika
Perreault, Leigh
Hulman, Adam
Witte, Daniel R.
Brunner, Eric J.
Tabák, Adam
Jørgensen, Marit E.
Færch, Kristine
Funding for this research was provided by:
University College London
Article History
Received: 28 February 2019
Accepted: 10 April 2019
First Online: 23 May 2019
Duality of interest
: KF is funded by the Novo Nordisk Foundation. LP reports personal fees from Novo Nordisk, Merck Astra Zeneca, Boeringer-Ingelheim, Orexigen, Sanofi and Janssen. MK reports research grants from the UK Medical Research Council (K013351, R024227, S011676), NordForsk, Academy of Finland and Helsinki Institute of Life Science during the conduct of the study. MEJ has received research grants from AstraZeneca, AMGEN AB, Sanofi Aventis and Boehringer-Ingelheim (Investigator-initiated research). The other authors declare no competing interests.